Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

This presents a challenge, however, given the multitude of vaccine approaches currently being tested and the even greater number of vaccine target antigens being evaluated. In a recent report by ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

More recently, they turned to immunotherapy to target tumors more precisely. These approaches include monoclonal antibodies against tumor antigens, checkpoint inhibitors that block tumors from ...

Clinical outcomes from a prospective study of comprehensive genomic testing in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the ...

[1] These antigens were drawn from the PubMed database over the last 5 years using the term 'cancer vaccine target'. The major criteria for formulating this ranking included: Evidence of antitumor ...